IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,742,142 | -8.8% | 284,750 | +0.8% | 0.03% | -3.4% |
| Q2 2023 | $3,007,077 | -84.8% | 282,620 | -85.0% | 0.03% | -85.4% |
| Q1 2023 | $19,843,318 | -4.4% | 1,886,247 | +12.6% | 0.20% | -8.7% |
| Q4 2022 | $20,759,309 | +19.4% | 1,675,489 | -0.2% | 0.22% | +10.7% |
| Q3 2022 | $17,386,000 | +1.0% | 1,678,211 | +12.4% | 0.20% | +11.3% |
| Q2 2022 | $17,222,000 | +17.9% | 1,493,637 | +28.7% | 0.18% | +42.7% |
| Q1 2022 | $14,603,000 | +160.4% | 1,160,846 | +141.4% | 0.12% | +195.2% |
| Q4 2021 | $5,607,000 | +23262.5% | 480,849 | +20555.0% | 0.04% | – |
| Q2 2020 | $24,000 | +26.3% | 2,328 | +24.8% | 0.00% | – |
| Q1 2020 | $19,000 | – | 1,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |